持续性房颤一线PVI线性消融联合Marshall静脉乙醇输注
本前瞻性队列研究纳入87例持续性房颤患者,评估一线采用肺静脉隔离联合线性消融方案并联合Marshall静脉乙醇输注的可行性与安全性。78例成功完成联合治疗,手术时间及透视时间较短,提示该策略可行。同时比较花篮式与花篮加花瓣式二尖瓣峡部消融流程,后者显著降低急性二尖瓣峡部再连接率。
要点
- 一线PVI线性消融联合Marshall静脉乙醇输注在持续性房颤中可行且安全。
- 花篮加花瓣式流程可显著降低急性二尖瓣峡部再连接。
- Marshall静脉插管或输注失败率为10.3%。
核心结论
- 持续性房颤患者一线采用肺静脉隔离联合线性消融方案并联合Marshall静脉乙醇输注是可行、安全且高效的。
- 花篮加花瓣式流程相比单纯花篮式流程可显著降低急性二尖瓣峡部再连接,提高手术持久性。
研究设计与样本
- 前瞻性队列研究,纳入2024年4月至2025年9月期间87例持续性房颤患者。
- 所有患者均采用Farapulse系统进行脉冲场消融,流程顺序为Marshall静脉乙醇输注、左侧肺静脉隔离、二尖瓣峡部线消融、顶部线消融、右侧肺静脉隔离。
- 手术结束时等待15分钟后重新评估顶部线及二尖瓣峡部线。
主要发现
- 87例患者中9例Marshall静脉插管或输注失败,失败率为10.3%。
- 78例患者成功接受联合治疗,平均年龄70.3±8.9岁,女性占30.8%。
- 平均CHA2DS2-VASc评分为3.0±1.6,平均左心室射血分数为59±12%。
- 平均左心房表面积为26.3±4.5 cm²,平均左心房容积指数为51±23 mL/m²。
- 总手术时间为51.9±9分钟,透视时间为12.7±4.5分钟。
关键数值与推荐
- Marshall静脉插管或输注失败率为10.3%(9/87)。
- 脉冲场消融阶段手术时间为22.7±7分钟,透视时间为6.7±2.3分钟。
- 总透视时间为12.7±4.5分钟。
临床怎么用
- 对于持续性房颤患者,可考虑一线采用肺静脉隔离联合线性消融方案并联合Marshall静脉乙醇输注。
- 二尖瓣峡部消融推荐采用花篮加花瓣式流程以降低急性再连接风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Graphical Abstract Text. Mitral ablation and pulsed field ablation (PFA). PFA using a PVI-LP plus VOMEI first-line strategy in persistent AF is feasible, safe, and efficient. A basket + flower workflow significantly reduces acute mitral isthmus reconnection, improving procedural durability and supporting optimized PFA strategies. ABSTRACT Introduction Different ablation strategies and energy sources have been developed for the treatment of persistent atrial fibrillation (PeAF), but the optimal early management remains controversial. In patients with PeAF, the safety and efficacy of an early linear strategy combining pulsed field ablation (PFA) with vein of Marshall ethanol infusion (VOMEI) have not yet been evaluated. Objective This prospective cohort study aimed to: (1) assess the safety and feasibility of a pulmonary vein isolation plus linear plan (PVI-LP) combined with VOMEI as a first-line therapy in patients with PeAF; and (2) evaluate the most effective PFA workflow for mitral isthmus (MI) ablation, comparing a flower-only approach with a basket + flower strategy integrated with the Faraview system. Methods Between April 2024 and September 2025, 87 consecutive patients with PeAF were referred for PFA using a PVI-LP strategy combined with VOMEI. The procedural workflow consisted of VOMEI first, followed by left PVI, MI line ablation, roof line ablation, and finally right PVI. At the end of the procedure, both the roof line and the MI line were reassessed after a 15-min waiting period. All procedures were performed using the Farapulse system. Results Eighty-seven patients undergoing a PVI-LP plus VOMEI approach as first-line therapy were initially included. Marshall vein cannulation or infusion failure occurred in 9/87 patients (10.3%). Thus, 78 patients (89.7%) successfully underwent PFA with the PVI-LP plus VOMEI approach and were included in the final analysis. Baseline clinical and echocardiographic characteristics were as follows: mean age 70.3 ± 8.9 years, 30.8% women, mean CHA2DS2-VASc score 3.0 ± 1.6, mean left ventricular ejection fraction 59 ± 12%, mean left atrial surface area 26.3 ± 4.5 cm2, and mean indexed left atrial volume 51 ± 23 mL/m2. Procedural time and fluoroscopy time were 51.9 ± 9 and 12.7 ± 4.5 min for the overall procedure, 9.4 ± 2.9 and 3.3 ± 2.2 min for VOMEI, 4.8 ± 4.7 and 2.7 ± 2.9 min for transseptal puncture, and 22.7 ± 7 and 6.7 ± 2.3 min for PFA, respectively. The rate of 15-min MI reconnection despite VOMEI decreased
引用
- Journal of Cardiovascular Electrophysiology:First‐Line PVI‐Linear Plan With Pulsed Field Ablation and Vein of Marshall Ethanol Infusion in Persistent Atrial Fibrillation: Safety, Feasibility, and Mitral Isthmus Workflow Optimization
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。